UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 329

Sortiert nach

Netting neutrophils in autoimmune small-vessel vasculitis

Nature medicine, 2009-06, Vol.15 (6), p.623-625

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis

Current opinion in rheumatology, 2010-01, Vol.22 (1), p.43-48

2010

Link zum Volltext

Verfügbarkeit prüfen

Genetic predisposition ( NLRP3 V198M mutation) for IL-1–mediated inflammation in a patient with Schnitzler syndrome

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.500-502

2010

Link zum Volltext

Verfügbarkeit prüfen

Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway

Blood, 2006-06, Vol.107 (11), p.4440-4448

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical manifestations and treatment of Wegener's granulomatosis

Rheumatic diseases clinics of North America, 2010-08, Vol.36 (3), p.507

2010

Link zum Volltext

Verfügbarkeit prüfen

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

Seminars in arthritis and rheumatism, 2003-04, Vol.32 (5), p.273-284

2003

Link zum Volltext

Verfügbarkeit prüfen

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.1011-1017

2013

Link zum Volltext

Verfügbarkeit prüfen

Maintien de la rémission sans biothérapie chez les patients adultes atteints de vascularite à ANCA : revue systématique de la littérature et méta-analyse en réseau

Revue du rhumatisme (Ed. française : 1993), 2014-07, Vol.81 (4), p.318-323

2014

Link zum Volltext

Verfügbarkeit prüfen

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.327-333

2012

Link zum Volltext

Verfügbarkeit prüfen

Getting rid of MPO-ANCA: a matter of disease subtype

Rheumatology (Oxford, England), 2013-04, Vol.52 (4), p.752-754

2013

Link zum Volltext

Verfügbarkeit prüfen

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

Annals of internal medicine, 2009-05, Vol.150 (10), p.670

2009

Link zum Volltext

Verfügbarkeit prüfen

Advances in the therapy of Wegenerʼs granulomatosis

Current opinion in rheumatology, 2006-01, Vol.18 (1), p.25-32

2006

Link zum Volltext

Verfügbarkeit prüfen

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Rheumatology (Oxford, England), 2014-05, Vol.53 (5), p.882-889

2014

Link zum Volltext

Verfügbarkeit prüfen

Neurological involvement in Wegenerʼs granulomatosis

Current opinion in rheumatology, 2011-01, Vol.23 (1), p.7-11

2011

Link zum Volltext

Verfügbarkeit prüfen

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Annals of the rheumatic diseases, 2010-11, Vol.69 (11), p.1934-1939

2010

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014

Nephrology, dialysis, transplantation, 2015-04, Vol.30 Suppl 1 (suppl_1), p.i46-i52

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of ANCA-associated vasculitides (AAV)

Autoimmunity reviews, 2013-02, Vol.12 (4), p.483-486

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment of ANCA-associated vasculitis

Nature reviews. Nephrology, 2014-01, Vol.10 (1), p.25

2014

Link zum Volltext

Verfügbarkeit prüfen

Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

Arthritis and rheumatism, 2005-02, Vol.53 (1), p.93-99

2005

Link zum Volltext

Verfügbarkeit prüfen

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

Annals of the rheumatic diseases, 2007-05, Vol.66 (5), p.605-617

2007

Link zum Volltext

Verfügbarkeit prüfen

Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage

Rheumatology (Oxford, England), 2013-05, Vol.52 (5), p.875-882

2013

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in the pharmacotherapy of Churg-Strauss syndrome

Expert opinion on pharmacotherapy, 2004-01, Vol.5 (1), p.25-35

2004

Link zum Volltext

Verfügbarkeit prüfen

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.704-704

2011

Link zum Volltext

Verfügbarkeit prüfen

Current State of Biologicals in the Management of Systemic Vasculitis

Annals of the New York Academy of Sciences, 2007-09, Vol.1110 (1), p.261-270

2007

Link zum Volltext

Verfügbarkeit prüfen

Progranulin antibodies in autoimmune diseases

Journal of autoimmunity, 2013-05, Vol.42, p.29-38

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 329

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(226)
Humans
(225)
Life Sciences & Biomedicine
(217)
Biological And Medical Sciences
(110)
Male
(106)
Female
(102)
Medical Sciences
(100)
Middle Aged
(91)
Rheumatology
(90)
Adult
(78)
Aged
(61)
Granulomatosis With Polyangiitis - Immunology
(54)
Immunology
(45)
Wegener's Granulomatosis
(38)
Adolescent
(32)
Immunosuppressive Agents - Therapeutic Use
(27)
Antibodies, Antineutrophil Cytoplasmic - Blood
(26)
Vasculitis
(26)
Granulomatosis With Polyangiitis - Drug Therapy
(25)
Anca
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Netting neutrophils in autoimmune small-vessel vasculitis

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis

Genetic predisposition ( NLRP3 V198M mutation) for IL-1–mediated inflammation in a patient with Schnitzler syndrome

Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway

Clinical manifestations and treatment of Wegener's granulomatosis

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

Maintien de la rémission sans biothérapie chez les patients adultes atteints de vascularite à ANCA : revue systématique de la littérature et méta-analyse en réseau

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Getting rid of MPO-ANCA: a matter of disease subtype

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

Advances in the therapy of Wegenerʼs granulomatosis

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Neurological involvement in Wegenerʼs granulomatosis

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014

Treatment of ANCA-associated vasculitides (AAV)

Treatment of ANCA-associated vasculitis

Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage

Recent progress in the pharmacotherapy of Churg-Strauss syndrome

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis

Current State of Biologicals in the Management of Systemic Vasculitis

Progranulin antibodies in autoimmune diseases

Suchergebnisse filtern